COMP <GO>
NDSN vs TMO // ENTERPRISE SCALE & MARKET CAP
Nordson Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NDSN 10
— TMO 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $322.67 (-1.95%) • MKT CAP: $18.33B
market-cap
$18.33B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NDSN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NDSN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.20% | 41.00% | +14.20 | NDSN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.40% | 9.30% | +2.10 | NDSN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.5x | 30.4x | -3.90 | NDSN | /valuation <GO> |
| Free Cash Flow Yield | 3.61% | 2.40% | +1.21 | NDSN | /fcf-yield <GO> |
| Operating Margin | 25.50% | 17.40% | +8.10 | NDSN | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 15.10% | +2.30 | NDSN | /net-margins <GO> |
| Revenue Growth (YoY) | 3.80% | 3.90% | -0.10 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.98% | 0.24% | +0.74 | NDSN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.97 | 4.50 | +1.47 | NDSN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | NDSN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 59.1 | -11.38 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.94 | -0.03 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.2x | 36.3x | -1.10 | NDSN | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $18.33B | $262.22B | -$243.89B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NDSN REV | TMO REV | NDSN GROSS % | TMO GROSS % | NDSN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.79B | $44.56B | 55.2% | 44.0% | $661.1M | $6.29B |
| FY 2024 | $2.69B | $42.88B | 55.2% | 44.0% | $491.8M | $7.27B |
| FY 2023 | $2.63B | $42.86B | 44.0% | 44.0% | $523.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NDSN // BETA 0.91
TMO // BETA 0.94